• Mr. Anthony
Aglione, Associate Principal Scientist, Roche Discovery Technologies, Hoffmann-La
Roche, Inc.
• Dr. Robert Blake, Senior Scientist, Target Discovery, Exelixis
• Dr. Michael Bova, Staff Scientist, Pharmacology, Elan Pharmaceuticals, plc
• Dr. Jeremy S. Caldwell, Director of Molecular and Cell
Biology, Genomics Institute of the Novartis
Research Foundation (GNF)
• Dr. Miroslav Cik, Principal Scientist, Department of AD&HTS, Johnson & Johnson Pharmaceutical
Research & Development
• Dr. James W. Dennis, Canada Research Chair, Senior Investigator & Professor, Microbiology and
Medical Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital
• Dr. Claudia Derian, Research Fellow, Drug Discovery, Johnson & Johnson Pharmaceutical Research
& Development, L.L.C.
• Dr. John Dunlop, Associate Director, Discovery Neuroscience,
Wyeth Research
• Dr. Christophe J. Echeverri, CEO, CSO, Cenix BioScience
GmbH
• Dr. Paul Elvin, Principal Scientist, Cancer Bioscience,
AstraZeneca
• Dr. James G. Evans, CSBi Research Scientist, Whitehead
MIT BioImaging Center
• Dr. Myles Fennell, Principal Research Scientist I, Neuroscience, Wyeth Research
• Mr. Leon S. Garfinkel, Director, Informatics & Infrastructure,
Preclinical Discovery Research,
Hoffmann-La Roche, Inc.
• Dr. Ralph Garippa, Research Leader, Roche Discovery Technologies, Hoffmann-La Roche, Inc.
• Dr. Joe W. Gray, Director, Life Sciences Division, Lawrence
Berkeley National Laboratory
• Dr. Stephen J. Haggarty, Harvard University, Eli & Edythe
Broad Institute, Chemical Biology Program
• Ms. Shannon Hamilton, Senior Scientist, Roche Discovery
Technologies, Hoffmann-La Roche, Inc.
• Dr. Steven Haney, Principal Scientist/Group Leader, Oncology
Genomics, Wyeth Research
• Dr. Ralf Heilker, Senior Scientist, Integrated Lead Discovery,
Boehringer Ingelheim Pharma GmbH &
Co. KG
• Ms. Ann Hoffman, Senior Principal Scientist, Roche Discovery
Technologies, Hoffmann-La Roche, Inc.
• Dr. Paul A. Johnston, Research Advisor, Eli Lilly and Co.
• Dr. John Kerrison, Assistant Professor, Ophthalmology,
Wilmer Eye Institute, Johns Hopkins Hospital
• Mr. Aidas Kriauciunas, Research Scientist, Integrative Biology,
Eli Lilly and Co.
• Dr. Mark A. Labow, Executive Director, Functional
Genomics, Novartis Institute for Biomedical
Research
• Dr. Kurt Langenbach, Research Biologist, Cell and Tissue
Measurements Group, Biotechnology
Division, National Institute of Standards and Technology
• Dr. Jonathan Lee, Research Advisor, Lead Optimization Biology, Eli Lilly and Co.
• Dr. Julie (Zhuyin) Li, Head of Assay Development and Screening, Lead Identification Technology,
sanofi-aventis
• Dr. Spyro Mousses, Director, Cancer Drug Development Laboratory, Translational Genomics
Research Institute
• Dr. Robert F. Murphy, Professor of Biological Sciences and
Biomedical Engineering; and Director,
Merck Computational Biology and Chemistry Program, Carnegie Mellon University
• Dr. Carmel Nanthakumar, Senior Research Scientist, Automated Imaging, Merck Sharp & Dohme
• Dr. Stefan Prechtl, Group Leader, Subcellular Imaging,
Enabling Technologies, AD-HTS, Schering AG
• Dr. Berta Strulovici, Executive Director, Automated Biotechnology, Merck & Co., Inc.
• Dr. Flora Tang, Associate Director, Molecular Pharmacology,
Amgen, Inc.
• Dr. O. Joseph Trask, Jr., Associate Senior Biochemist, Eli Lilly
and Co.
• Dr. Andreas Vogt, Research Assistant Professor, Department of
Pharmacology; and Associate
Director, Fiske Drug Discovery Laboratory, University of Pittsburgh School of Medicine
• Mrs. Hong Xiao, Research Scientist, Applied Genomics, Bristol-Myers Squibb Company |
